Glycomine
PrivateLast Round
Series C
Apr 16, 2025
Total Funding Raised
$195M
Momentum Score
25 /100
Company Overview
Glycomine is a biopharmaceutical company that develops orphan drugs aimed at treating rare metabolic disorders and protein misfolding through innovative replacement therapies and targeted intracellular delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycomine Comps
Public and private peers based on sector, stage, and business model.
Glycomine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2025 | ||||
| Series B Extension | Jun 23, 2021 | ||||
| Series B | Aug 7, 2019 | ||||
| Series A | Nov 16, 2016 |
Glycomine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aberdeen Group | Series C |
| Mesa Verde Venture Partners | Series A |
| CTI Life Sciences Fund | Series C |
| abrdn Inc. | Series C |
| Remiges Ventures | Series C, Series B Extension |
| Advent Life Sciences | Series C |
| BioInnovation Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2025
$115M round raised
Glycomine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glycomine's valuation, stock price, and market status.
